Dr. Rafael Arturo Penunuri, MD

Dr. Penunuri practices at Superior Family Medical Group in Newport Beach, California.

Dr. Penunuri's NPI, 1831270362, was assigned on October 18, 2006. Dr. Penunuri graduated from David Geffen School of Medicine at UCLA in 1982. Dr. Penunuri holds California license G50737.

Dr. Penunuri's primary practice is Superior Family Medical Group, at 1419 Superior Ave, Newport Beach, CA 92663-2723. The practice phone is (949) 650-0587.

Dr. Penunuri's primary practice is Superior Family Medical Group in Newport Beach, California. Dr. Penunuri is also affiliated with Hoag Hospital Newport Beach. The medical group on file is Remedial Patient Care. Dmand AI also links Dr. Penunuri to 5 more home health agencies, 4 group practices and clinics, 4 medical groups, 3 physician offices and 3 hospices, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Penunuri practices, 17 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Penunuri's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Penunuri is board certified in addiction medicine by the American Board of Addiction Medicine. Dmand AI has Dr. Penunuri's licenses on file in 2 states: California and Hawaii.

Dmand AI lists acid reflux, acute sinusitis, alcohol use disorders, alzheimer's disease, aneurysm, anxiety, arthritis and asthma among the conditions Dr. Penunuri treats.

CMS data shows 14,016 Medicare services from Dr. Penunuri across 34 procedure codes in 2024, for 1,634 Medicare patients. Medicare paid $1,201,928 for them. Every service was in an office.

CMS counts 1,634 Medicare patients who saw Dr. Penunuri in 2024. The largest group is 65 to 74, with 694 patients. 75% of them have arthritis, and 75% have high blood pressure. 86% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Penunuri's median patient age at 63, with 53% women.

In 2024, Dr. Penunuri wrote 3,002 Medicare Part D claims for 244 patients. 90% of them were for generic drugs. CMS names the drug for 2,340 of them, across 62 drugs with 11 or more claims each, at $186,861 in total drug cost. In 2023, CMS named 2,117 claims across 60 drugs.

Dr. Penunuri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Penunuri as offering telehealth. CMS counts 41 procedures of removal of tissue by Dr. Penunuri, more than 76% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 392 general payments to Dr. Penunuri from 53 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Indivior Inc. paid the most, $873.

Dmand AI lists 1 award for Dr. Penunuri, most recently CMS Stage 1 EHR in 2013.

Dr. Penunuri graduated from David Geffen School of Medicine at UCLA in 1982.

Dr. Penunuri is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.